Donato Barbato

⁶⁸Ga/¹⁷⁷Lu-NeoBOMB1, a Novel Radiolabeled GRPR Antagonist for Theranostic Use in Oncology

Simone U. Dalm, Ingrid L. Bakker, Erik de Blois et al. · Journal of Nuclear Medicine · 2016 · 125 citations · Full text

Medicine, Oncology, Pharmacology +17

NeoBOMB1, a GRPR-Antagonist for Breast Cancer Theragnostics: First Results of a Preclinical Study with [67Ga]NeoBOMB1 in T-47D Cells and Tumor-Bearing Mice

Aikaterini Kaloudi, Emmanouil Lymperis, Athina Giarika et al. · Molecules · 2017 · 35 citations · Full text

Medicine, Oncology, Pharmacology +16

In Vivo Biodistribution and Efficacy Evaluation of NeoB, a Radiotracer Targeted to GRPR, in Mice Bearing Gastrointestinal Stromal Tumor

Christopher Montemagno, Florian Raes, Mitra Ahmadi et al. · Cancers · 2021 · 21 citations · Full text

Medicine, Oncology, Pharmacology +15

Preclinical Validation of ^99m Tc–Annexin A5–128 in Experimental Autoimmune Myocarditis and Infective Endocarditis: Comparison with ^99m Tc–HYNIC–Annexin A5

Khadija Benali, Liliane Louedec, Rana Ben Azzouna et al. · Molecular Imaging · 2015 · 20 citations · Full text

Medicine, Nuclear Medicine, Pharmacokinetics +15

COVID-19 Patient Management in Outpatient Setting: A Population-Based Study from Southern Italy

Salvatore Crisafulli, Valentina Ientile, Luca L’Abbate et al. · Journal of Clinical Medicine · 2021 · 16 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14